A detailed history of Ethic Inc. transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Ethic Inc. holds 19,793 shares of VRTX stock, worth $9.2 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares
19,793
Previous 21,162 6.47%
Holding current value
$9.2 Million
Previous $9.92 Million 7.2%
% of portfolio
0.23%
Previous 0.24%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$460.0 - $505.78 $629,740 - $692,412
-1,369 Reduced 6.47%
19,793 $9.21 Million
Q2 2024

Aug 13, 2024

BUY
$392.81 - $485.53 $537,756 - $664,690
1,369 Added 6.92%
21,162 $9.92 Million
Q1 2024

May 13, 2024

BUY
$407.69 - $446.08 $879,387 - $962,194
2,157 Added 12.23%
19,793 $8.27 Million
Q4 2023

Feb 14, 2024

BUY
$343.0 - $410.68 $387,933 - $464,479
1,131 Added 6.85%
17,636 $7.18 Million
Q3 2023

Nov 14, 2023

BUY
$338.18 - $362.46 $598,240 - $641,191
1,769 Added 12.0%
16,505 $5.74 Million
Q2 2023

Aug 14, 2023

BUY
$314.42 - $351.91 $447,105 - $500,416
1,422 Added 10.68%
14,736 $5.19 Million
Q1 2023

May 12, 2023

BUY
$283.23 - $323.1 $1.31 Million - $1.49 Million
4,611 Added 52.98%
13,314 $4.19 Million
Q4 2022

Feb 14, 2023

BUY
$285.76 - $321.48 $392,062 - $441,070
1,372 Added 18.72%
8,703 $2.51 Million
Q3 2022

Nov 14, 2022

BUY
$273.83 - $305.53 $363,098 - $405,132
1,326 Added 22.08%
7,331 $2.12 Million
Q2 2022

Aug 10, 2022

BUY
$234.96 - $292.55 $859,013 - $1.07 Million
3,656 Added 155.64%
6,005 $1.69 Million
Q1 2022

May 16, 2022

BUY
$221.42 - $260.97 $34,762 - $40,972
157 Added 7.16%
2,349 $613,000
Q4 2021

Feb 14, 2022

SELL
$177.01 - $223.45 $335,256 - $423,214
-1,894 Reduced 46.35%
2,192 $481,000
Q3 2021

Nov 15, 2021

SELL
$181.39 - $202.99 $22,492 - $25,170
-124 Reduced 2.95%
4,086 $741,000
Q2 2021

Aug 10, 2021

BUY
$187.49 - $221.1 $140,430 - $165,603
749 Added 21.64%
4,210 $849,000
Q1 2021

May 13, 2021

BUY
$207.02 - $241.31 $199,981 - $233,105
966 Added 38.72%
3,461 $744,000
Q4 2020

Feb 10, 2021

SELL
$207.01 - $276.09 $21,529 - $28,713
-104 Reduced 4.0%
2,495 $590,000
Q3 2020

Oct 27, 2020

BUY
$255.65 - $303.1 $59,055 - $70,016
231 Added 9.76%
2,599 $707,000
Q2 2020

Aug 12, 2020

BUY
$225.48 - $295.8 $320,181 - $420,036
1,420 Added 149.79%
2,368 $687,000
Q1 2020

May 15, 2020

BUY
$199.77 - $247.81 $189,381 - $234,923
948 New
948 $226,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $119B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Ethic Inc. Portfolio

Follow Ethic Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ethic Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ethic Inc. with notifications on news.